Cargando…
Development and Qualification of Physiologically Based Pharmacokinetic Models for Drugs With Atypical Distribution Behavior: A Desipramine Case Study
Desipramine is a secondary tricyclic amine, which is primarily metabolized by cytochrome 2D6. It shows a high volume of distribution (Vss) (10–50 L/kg) due to its high lipophilicity, unspecific phospholipid binding, and lysosomal trapping. The objective of this study was to develop and qualify a phy...
Autores principales: | Samant, TS, Lukacova, V, Schmidt, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697013/ https://www.ncbi.nlm.nih.gov/pubmed/28398693 http://dx.doi.org/10.1002/psp4.12180 |
Ejemplares similares
-
Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug–Drug Interactions of Phenytoin
por: Rodriguez-Vera, Leyanis, et al.
Publicado: (2023) -
Anti-inflammatory properties of desipramine and fluoxetine
por: Roumestan, Caroline, et al.
Publicado: (2007) -
Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective
por: Shebley, Mohamad, et al.
Publicado: (2018) -
Report from the EMA workshop on qualification and reporting of physiologically based pharmacokinetic (PBPK) modeling and simulation
por: Zhao, P
Publicado: (2017) -
A model qualification method for mechanistic physiological QSP models to support model‐informed drug development
por: Friedrich, CM
Publicado: (2016)